My current research activities are focused on breast cancer and comprise targeted therapy in HR+/HER2- advanced breast cancer, the utility of liquid biopsy and PET/CT in response assessment; the combination of targeted therapy with stereotactic radiotherapy, assessment of early response to neoadjuvant chemotherapy with molecular markers and PET/CT, personalized and adaptive therapy in refractory disease and subpopulations with dismal prognosis. Memorial Sloan Kettering Cancer Center, New York City, USA, International Observer, 2022 ESMO Fellowship at Champalimaud Cancer Center, Lisbon, Portugal, 2023